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Abstract
Objective Since screening for cancer has been advocated,
funded, and promoted in France, it is important to evaluate
theattitudesofsubjectsinthegeneralpopulationandgeneral
practitioners (GPs) toward cancer screening strategies.
Methods EDIFICE is a nationwide opinion poll that was
carried out by telephone among a representative sample of
1,504 subjects living in France and aged between 40 and
75 years and among a representative sample of 600 GPs.
The questionnaire administered to subjects queried about
previous screening for cancer.
Results Ninety-three percent of women stated that they
had undergone at least one mammography. Although rated
‘‘A’’ recommendation—strongly recommended—by the
US Preventive Services Task Force, screening for colo-
rectal cancer received less attention than prostate cancer
screening which is rated ‘‘I’’—insufﬁcient evidence—
(reported screening rates of 25% and 36%, respectively).
Six percent of subjects stated that they had undergone lung
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showed similar inconsistencies.
Conclusions It thus appears that understanding of cancer
screening practices in the French general population does
not match scientiﬁc evidence. To a lesser extent, this also
holds for GPs.
Keywords Mass-screening  Compliance 
Health care opinion poll  Health services research 
Health services misuse
Introduction
Early detection of cancer can theoretically prolong overall
survival of the screened subjects. Reductions in cancer-
relatedmortalityhavebeendemonstratedformammography
forbreastcancer(BC)andfecaloccultbloodtest(FOBT)for
colorectal cancer (CRC) [1, 2]. For these two cancers, mass-
screening programs are implemented in France, in which
targeted subjects are contacted by mail. The US Preventive
Services Task Force guidelines rate CRC screening as ‘‘A’’
(strongly recommended), BC screening as ‘‘B’’ (recom-
mended),andbothprostatecancer(PC)andlungcancer(LC)
screenings as ‘‘I’’ (evidence insufﬁcient to come down in
favor or against screening) [3]. The objectives of the
nationwideEDIFICEopinionpollcarriedoutinFrancewere
to collect data at the national level (the level of funding)
about (1) subjects’ individual access to cancer screening
procedures(throughorganizedprogramsoronsubjects’own
initiative)and(2)aboutgeneralpractitioners’(GPs)attitudes
toward cancer screening. Four frequent cancer types were
selected on the grounds of their different screening statuses:
BC and CRC for evidence of efﬁcacy of screening and
existence of a national screening program and prostate and
lungcancersforneitherevidenceofefﬁcacyofscreeningnor
ofﬁcial screening program.
Methods
General population opinion poll
The population-based EDIFICE opinion poll was carried
out by telephone from 18 January to 2 February, 2005
among a representative sample of 1,504 subjects living in
France and between 40 and 75 years old (1,609 subjects
minus 105 who had already been affected by cancer).
Sample representativeness was assessed, in relation to the
statistics of the French Employment Survey in year 2002
[4], based on the following criteria: sex, age (ﬁve catego-
ries), profession (eight categories), community size (ﬁve
categories), and regional distribution (nine categories).
General practitioner opinion poll
Anationwideopinionpollwascarriedoutbytelephonefrom
31 January to 18 February, 2005 among a representative
sample of 600 GPs practicing in France. Sample represen-
tativeness was assessed based on the following criteria: age
(four categories) and regional distribution (ﬁve categories).
Results
The main results of EDIFICE opinion poll are summarized
in Fig. 1. Almost all (93%) interviewed women stated that
they had undergone at least one mammography. In con-
trast, 25%, 36%, and 6% of the interviewed subjects stated
that they had undergone screening tests for CRC, PC, and
LC, respectively.
The corresponding percentages of GPs who stated that
they recommended cancer screening tests to their patients
were consistent with the proportions of subjects who had
undergone screening tests for each tumor type: 68%, 18%,
58%, and 4% of the interviewed GPs stated that they sys-
tematically recommended screening for BC, CRC, PC and
LC, respectively.
Reasons given to explain why screening tests had not
been performed
Physicians and subjects provided contrasting answers as
to why cancer-screening tests had not been performed.
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Fig. 1 Adherence to cancer screening strategies according to the
French nationwide EDIFICE opinion poll (1,504 subjects, 600 general
practitioners). In France, there are organized mass-screening pro-
grams for breast cancer by mammography (100% of the population
covered at the time of the opinion poll) and for colorectal cancer
using Hemoccult (almost 30% of the population covered). In contrast,
there is no mass-screening program for prostate cancer and lung
cancer. For subjects in the general population, ﬁgures indicate the
rates of subjects stating that they had undergone at least one screening
test. For general practitioners, ﬁgures indicate the rates of general
practitioners stating that they systematically recommended cancer
screening
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123Physicians mainly focused on subjects’ fears while subjects
denied this reason. Fear of results was cited by 44% of
physicians as the main explanation why subjects did not
undergoBCscreeningtests versusonly18%ofsubjects.For
CRC screening, the ﬁgures were 16% and 3%, respectively.
The corresponding odds ratios for fear being elicited by
subjects versus GPs as the reason for not undergoing BC or
CRC screening tests were 0.29 and 0.15, respectively
(Table 1). Furthermore, subjects focused on a lackof advice
on cancer screening from their physicians whereas GPs
rarelydidso.Lackofadvicefromthephysicianswascitedby
11% of subjects as the main explicative factor for subjects
not undergoing BC screening tests versus only 1% of GPs.
For CRC screening, the ﬁgures were 16% and 9%, respec-
tively. The corresponding odds ratios for lack of medical
advicebeingelicitedbysubjectsversusGPsasthereasonfor
subjects not undergoing BC or CRC screening tests were
11.65 and 1.93, respectively (Table 1).
Discussion
In the present study, we describe the adherence to different
screening programs for four types of cancers (BC, CRC,
PC, and LC) in France. It is important to point out that this
opinion poll does not report an accurate incidence of sub-
jects actually screened for cancer but indeed the proportion
of subjects stating that they had undergone at least one
screening test. It is also worth mentioning that the French
national health insurance system currently makes the cor-
responding screening tests (FOBT, mammography,
prostate speciﬁc antigen—PSA—testing and X-ray) avail-
able for free (or almost free) to all afﬁliates.
The major ﬁnding of this report is the obvious disagree-
ment between evidence-based ofﬁcial recommendations and
actual practice is both subjects in the general population and
GPs in France. Despite a high level of evidence of reduction
in cancer-related mortality of similar magnitude (*15–20%)
with both BC and CRC mass-screenings [1, 2], 93% of
womenundergo mammographyscreening whereasonly 25%
of subjects in the same age range have access to CRC
screeningtools.Incontrast,36%ofmenagedbetween50and
74 yearshaveundergoneascreeningtestforPC(mainlyPSA
testing) even though the beneﬁt of PC screening remains
unknown [5].
EDIFICE showed, on the one hand, two ‘‘rational rates’’
of screening—high rate of women having undergone
mammography and low rate of subjects having performed
LC screening—and, on the other hand, two ‘‘inadequate
rates’’ of screening—abnormally low rate of CRC screen-
ing (nationwide coverage by the on-going program is
expected by the end of 2007) and abnormally high rate of
PC screening. Even more striking, the French GPs’
behavioral pattern of recommending individual cancer
screening exhibited the same inconsistencies.
Three reasons can be suggested to explain the observed
relationships between subjects’ and GPs’ behaviors. First,
subjects in the general population may be inﬂuenced by
medical counseling. Alternatively, physicians may endorse
their patients’ views and agree ‘‘under pressure’’ [6]. Lastly,
both subjects and GPs are exposed to similar not evidence-
supported recommendations/information, with the ‘‘magic
touch’’ofblood analysisforPCscreeningbeingattractiveto
them. Appropriate information of subjects and physicians,
including the possible beneﬁts and risks of PC screening
through PSA testing, could make these erroneous behaviors
less frequent [7].
Whereas GPs’ and subjects’ statements in EDIFICE
appeared in rather good agreement with respect to the
proportions of interviewed subjects having undergone
cancer screening tests and of GPs recommending cancer
screening to their patients, the reasons put forward why
screening tests were not performed are different, indeed
even opposite: based on their statements, GPs overesti-
mated the negative impact of fear of the results on subjects’
participation in cancer screening and they underestimated
their own role. Nevertheless, both GPs and subjects inter-
estingly seem to attach a more dreadful meaning to the
Table 1 Reasons cited by subjects in the general population and general practitioners why subjects did not undergo screening tests for breast
cancer (BC) or colorectal cancer (CRC)
Reasons cited For not undergoing BC screening tests For not undergoing CRC screening tests
Female subjects
N =3 8
General practitioners
N = 600
Subjects N = 725 General practitioners
N = 600
Subjects fearing the result n (%) 7 (18) 264 (44) 20 (3) 96 (16)
OR (CI95%) 0.29 (0.12–0.66) 0.15 (0.09–0.24)
Lack of physician’s advice n (%) 4 (11) 6 (1) 116 (16) 54 (9)
OR (CI95%) 11.65 (3.14–43.23) 1.93 (1.37–2.71)
OR indicates odds ratio; CI95% indicates conﬁdence interval at the risk a = 0.05
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123result of BC screening than to the result of CRC screening.
Indeed, fear of the result acting as a check upon carrying
out cancer screening tests was cited by 18% of the subjects
for BC screening whereas only 3% cited this reason for not
undergoing CRC screening tests. Comparatively, 44% and
16% of GPs cited fear of the result as the reason for sub-
jects not undergoing BC and CRC screening tests,
respectively.
It thus appears that there is a need for more research in
social science as well as in biology and public health to
improve the effectiveness of cancer screening in the
framework of a national health system.
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